Autophagy disruption provides clues to cancer development
Scientists have uncovered dementia-like behaviour in pancreas cells at risk of turning into cancer.
The findings provide clues that could help in the treatment and prevention of pancreatic cancer, a difficult-to-treat disease linked to 6,900 deaths in the UK every year.
The research was published in the journal Developmental Cell, and was funded by Cancer Research UK, with additional support from Wellcome, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council.
Researchers from the Cancer Research UK Scotland Centre studied pancreas cells in mice over time to see what was causing healthy cells to turn into cancer cells.
They discovered that pancreatic cells at risk of becoming cancerous, develop faults in the cell’s recycling process or autophagy.
In pre-cancer cells, the researchers noticed excess ‘problem protein’ molecules forming clumps – behaviour seen in neurological diseases such as dementia.
The researchers also noticed similar clumping occurring in human pancreas samples, suggesting this happens during pancreatic cancer development.
Cancer Research UK Senior Fellow at the Institute of Genetics and Cancer at the University of Edinburgh, Professor Simon Wilkinson, said: “Our research shows the potential role autophagy disruption plays in the beginnings of pancreatic cancer. While early stage, we can potentially learn from research into other diseases where we see protein clumping, such as dementia, to better understand this aggressive type of cancer and how to prevent it.”
The research suggests the combined effect of the faulty KRAS gene and disrupted autophagy could be driving the development of pancreatic cancer.
The researchers plan to study these processes in more detail, to see if they can help predict or possibly reverse the start of pancreatic cancer, and if factors like age, sex, or diet play a role.
Diana Turner, Senior Digital Content Editor, DDW
